vidarabine has been researched along with CACH Syndrome in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (80.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Clement, NF; Dietrich, J; Hochberg, EP; Martinez-Lage, M; Winter, SF | 1 |
Ross Reichard, R; Vaubel, RA | 1 |
Alberti, N; Crombe, A; De Roquefeuil, E; Dousset, V; Gilles, M; Guy, A; Tourdias, T | 1 |
Beitinjaneh, A; Cao, Q; McKinney, AM; Weisdorf, DJ | 1 |
Helton, KJ; Patay, Z; Triplett, BM | 1 |
1 review(s) available for vidarabine and CACH Syndrome
Article | Year |
---|---|
Toxic leukoencephalopathy following fludarabine-associated hematopoietic cell transplantation.
Topics: Antineoplastic Agents; Hematopoietic Stem Cell Transplantation; Humans; Leukoencephalopathies; Posterior Leukoencephalopathy Syndrome; Prodrugs; Vidarabine | 2011 |
4 other study(ies) available for vidarabine and CACH Syndrome
Article | Year |
---|---|
Fatal neurotoxicity after chimeric antigen receptor T-cell therapy: An unexpected case of fludarabine-associated progressive leukoencephalopathy.
Topics: Aged; Antineoplastic Agents; Fatal Outcome; Humans; Immunotherapy, Adoptive; Leukoencephalopathies; Lymphoma, Large B-Cell, Diffuse; Male; Neurotoxicity Syndromes; Retroperitoneal Neoplasms; Vidarabine | 2021 |
A 56-year-old woman with blindness and mental status changes.
Topics: Antineoplastic Agents; Blindness; Female; Humans; Leukoencephalopathies; Mental Disorders; Middle Aged; Vidarabine | 2018 |
Extensive acute toxic leukoencephalopathy induced by fludarabine: two months follow-up on brain MRI.
Topics: Antineoplastic Agents; Brain; Diagnosis, Differential; Diffusion Magnetic Resonance Imaging; Follow-Up Studies; Humans; Leukemia; Leukoencephalopathies; Male; Middle Aged; Treatment Outcome; Vidarabine | 2015 |
Fludarabine-induced severe necrotizing leukoencephalopathy in pediatric hematopoietic cell transplantation.
Topics: Adolescent; Child; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukoencephalopathies; Male; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Transplantation Conditioning; Vidarabine | 2013 |